SCHEMBL4199684

SCHEMBL4199684

C[C@@H](CC1CCCCC1)NCc1ccccc1NC(=O)C=CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
KDM4E B2RXH2 5/20 0.48
POLB P06746 2/20 0.48
MAPT P10636 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 3/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
HTT P42858 3/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP1A2 P05177 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LPAR2 Q9HBW0 1/20 0.40
LPAR3 Q9UBY5 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
ACKR3 P25106 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4199681 1.00 ALDH1A1 (0.48) ALDH1A1KDM4EPOLBMAPTPKM
SCHEMBL4192548 0.87 KMT2A (0.47) ALDH1A1KDM4EPOLBKMT2ASMN1; SMN2
SCHEMBL4196799 0.83 CCR3 (0.50) ALDH1A1KDM4EMAPTKMT2ASMN1; SMN2
SCHEMBL4195095 0.82 KMT2A (0.48) ALDH1A1POLBKMT2ASMN1; SMN2HTT
SCHEMBL4197445 0.82 KMT2A (0.48) ALDH1A1POLBKMT2ASMN1; SMN2HTT
SCHEMBL4196629 0.82 KMT2A (0.48) ALDH1A1POLBKMT2ASMN1; SMN2HTT
SCHEMBL4189874 0.81 KDM4E (0.43) ALDH1A1KDM4EPOLBKMT2ALMNA
SCHEMBL4197653 0.80 CTSL (0.45) KMT2ALMNASMN1; SMN2MEN1
SCHEMBL4195568 0.79 METAP2 (0.40) ALDH1A1KMT2ASMN1; SMN2HPGDMEN1
SCHEMBL14344023 0.78 NPC1 (0.36) KDM4EPKMKMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885KDM4E 3328/4885POLB 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.